Alamar Biosciences, Inc. (California) (ALMR)
30.83
-0.93
(-2.93%)
USD |
NASDAQ |
Nov 13, 16:00
30.83
0.00 (0.00%)
After-Hours: 19:59
Alamar Biosciences Total Assets (Quarterly) : 378.03M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 378.03M |
| June 30, 2026 | 390.98M |
| Date | Value |
|---|---|
| March 31, 2026 | 186.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Personalis, Inc. | 291.60M |
| 10X Genomics, Inc. | 1.063B |
| Champions Oncology, Inc. | 33.29M |
| Medpace Holdings, Inc. | 2.303B |
| Avantor, Inc. | 11.63B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 74.32M |
| Shareholders Equity (Quarterly) | 303.70M |
| Debt to Equity Ratio | 0.1394 |
| Current Ratio | 9.488 |
| Net Debt Paydown Yield | -0.36% |